Location: Greenwich, CT
CIK: 0001596452 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 9, 2022
Total Value: $242M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR S&P Biotech ETF | 150,000 | $13.48M | 5.6% | $89.88 | $111.19 | -19.2% | Cash Securities | 78464A870 |
| BSX | Boston Scientific Corp | 200,000 | $8.858M | 3.7% | $44.29 | $39.84 | +11.2% | Cash Securities | 101137107 |
| UNH | UnitedHealth Group Inc | 17,000 | $8.669M | 3.6% | $509.94 * | $353.54 | +35.2% | Cash Securities | 91324P102 |
| DHR | Danaher Corp | 27,500 | $8.067M | 3.3% | $293.35 * | $126.96 | +101.2% | Cash Securities | 235851102 |
| HUM | Humana Inc | 18,000 | $7.833M | 3.2% | $435.17 * | $351.42 | +19.3% | Cash Securities | 444859102 |
| THC | Tenet Healthcare Corp | 90,000 | $7.736M | 3.2% | $85.96 | $39.24 | +119.0% | Cash Securities | 88033G407 |
| TMO | Thermo Fisher Scientific Inc | 12,500 | $7.383M | 3.0% | $590.64 | $542.36 | +7.8% | Cash Securities | 883556102 |
| ELV | Anthem Inc | 15,000 | $7.368M | 3.0% | $491.20 * | $397.15 | +17.3% | Cash Securities | 036752103 |
| MCK | McKesson Corp | 22,500 | $6.888M | 2.8% | $306.13 | $159.43 | +88.4% | Cash Securities | 58155Q103 |
| UHS | Universal Health Services Inc | 47,500 | $6.885M | 2.8% | $144.95 | $125.78 | +13.0% | Cash Securities | 913903100 |
| ISRG | Intuitive Surgical Inc | 22,500 | $6.788M | 2.8% | $301.69 | $315.67 | -4.4% | Cash Securities | 46120E602 |
| JNJ | Johnson & Johnson | 35,000 | $6.203M | 2.6% | $177.23 * | $138.67 | +14.4% | Cash Securities | 478160104 |
| COR | AmerisourceBergen Corp | 40,000 | $6.188M | 2.6% | $154.70 * | $100.16 | +48.9% | Cash Securities | 03073E105 |
| AVTR | Avantor Inc | 180,000 | $6.088M | 2.5% | $33.82 | $20.57 | +64.4% | Cash Securities | 05352A100 |
| CVS | CVS Health Corp | 60,000 | $6.073M | 2.5% | $101.22 * | $82.41 | +7.7% | Cash Securities | 126650100 |
| CNC | Centene Corp | 70,000 | $5.893M | 2.4% | $84.19 | $82.02 | +2.6% | Cash Securities | 15135B101 |
| EHC | Encompass Health Corp | 82,392 | $5.859M | 2.4% | $71.11 * | $52.53 | +4.0% | Cash Securities | 29261A100 |
| CRL | Charles River Laboratories In | 20,000 | $5.679M | 2.3% | $283.95 | $247.50 | +14.7% | Cash Securities | 159864107 |
| HCA | HCA Healthcare Inc | 22,500 | $5.639M | 2.3% | $250.62 * | $172.44 | +40.7% | Cash Securities | 40412C101 |
| SYK | Stryker Corp | 20,000 | $5.347M | 2.2% | $267.35 * | $206.48 | +24.5% | Cash Securities | 863667101 |
| ABT | Abbott Laboratories | 45,000 | $5.326M | 2.2% | $118.36 * | $89.30 | +23.4% | Cash Securities | 002824100 |
| — | Laboratory Corp of America Ho | 20,000 | $5.273M | 2.2% | $263.65 | $166.12 | — | Cash Securities | 50540R409 |
| ZBH | Zimmer Biomet Holdings Inc | 40,000 | $5.116M | 2.1% | $127.90 * | $126.23 | -1.9% | Cash Securities | 98956P102 |
| NVO | Novo Nordisk A/S | 45,000 | $4.997M | 2.1% | $111.04 | $102.64 | +8.2% | Cash Securities | 670100205 |
| GMED | Globus Medical Inc | 65,000 | $4.796M | 2.0% | $73.78 | $70.47 | +4.7% | Cash Securities | 379577208 |
| CI | Cigna Corp | 20,000 | $4.792M | 2.0% | $239.60 * | $218.34 | +2.7% | Cash Securities | 125523100 |
| BAX | Baxter International Inc | 60,000 | $4.652M | 1.9% | $77.53 * | $73.64 | -3.7% | Cash Securities | 071813109 |
| IQV | IQVIA Holdings Inc | 20,000 | $4.624M | 1.9% | $231.20 | $179.69 | +28.7% | Cash Securities | 46266C105 |
| MDT | Medtronic PLC | 35,000 | $3.883M | 1.6% | $110.94 * | $93.67 | +5.6% | Cash Securities | G5960L103 |
| OPCH | Option Care Health Inc | 130,000 | $3.713M | 1.5% | $28.56 | $23.20 | +23.1% | Cash Securities | 68404L201 |
| CYH | Community Health Systems Inc | 300,000 | $3.561M | 1.5% | $11.87 | $12.90 | -8.0% | Cash Securities | 203668108 |
| — | Amedisys Inc | 20,000 | $3.446M | 1.4% | $172.30 | $172.30 | — | Cash Securities | 023436108 |
| — | LHC Group Inc | 20,000 | $3.372M | 1.4% | $168.60 | $168.60 | — | Cash Securities | 50187A107 |
| ACHC | Acadia Healthcare Co Inc | 50,000 | $3.277M | 1.4% | $65.54 | $58.09 | +12.8% | Cash Securities | 00404A109 |
| ABBV | AbbVie Inc | 20,000 | $3.242M | 1.3% | $162.10 * | $101.71 | +38.9% | Cash Securities | 00287Y109 |
| SGRY | Surgery Partners Inc | 57,020 | $3.139M | 1.3% | $55.05 | $49.46 | +11.3% | Cash Securities | 86881A100 |
| SEM | Select Medical Holdings Corp | 130,000 | $3.119M | 1.3% | $23.99 * | $16.64 | -27.3% | Cash Securities | 81619Q105 |
| BMRN | BioMarin Pharmaceutical Inc | 40,000 | $3.084M | 1.3% | $77.10 | $82.83 | -6.9% | Cash Securities | 09061G101 |
| NVST | Envista Holdings Corp | 60,000 | $2.923M | 1.2% | $48.72 | $46.13 | +5.6% | Cash Securities | 29415F104 |
| LLY | Eli Lilly & Co | 10,000 | $2.864M | 1.2% | $286.40 * | $191.90 | +44.4% | Cash Securities | 532457108 |
| INCY | Incyte Corp | 35,000 | $2.78M | 1.1% | $79.43 | $72.74 | +9.2% | Cash Securities | 45337C102 |
| GH | Guardant Health Inc | 40,000 | $2.65M | 1.1% | $66.25 | $90.31 | -26.6% | Cash Securities | 40131M109 |
| — | Seagen Inc | 17,500 | $2.521M | 1.0% | $144.06 | $144.06 | — | Cash Securities | 81181C104 |
| GRFS | Grifols SA | 200,000 | $2.336M | 1.0% | $11.68 | $11.51 | +1.5% | Cash Securities | 398438408 |
| CAH | Cardinal Health Inc | 40,000 | $2.268M | 0.9% | $56.70 * | $44.62 | +17.7% | Cash Securities | 14149Y108 |
| NBIX | Neurocrine Biosciences Inc | 22,500 | $2.109M | 0.9% | $93.73 | $84.75 | +10.6% | Cash Securities | 64125C109 |
| NTRA | Natera Inc | 50,000 | $2.034M | 0.8% | $40.68 | $81.93 | -50.4% | Cash Securities | 632307104 |
| MRNA | Moderna Inc | 10,000 | $1.723M | 0.7% | $172.30 | $168.36 | +2.3% | Cash Securities | 60770K107 |
| BNTX | BioNTech SE | 10,000 | $1.706M | 0.7% | $170.60 | $168.03 | +1.5% | Cash Securities | 09075V102 |